click enter text
still upsid lower pt year-end
mark target multipl rel group market multipl account
weaker end market growth datapoint see tool posit note
detail dhr defens organ acceler ge warrant
modest premium multipl vs tool reflect impli target
ex-dent ge-inclus asset consensu number hard pin
given vari treatment ge point apples-appl like
consensu estimate ep growth would
exclud benefit increment capit deploy worth like
stabil bioprocess analysi suggest faster growth like
break forma introduc detail bridg
pro-forma number simpl sum part analysi put dental
perspect part post ipo exhibit
ep estim busi pro forma ge deal
envista spin ep pro forma ge deal less
come model separ dental busi
sens consensu includ dental expect
guidanc includ dental specif item includ non-controlling interest
dental estim unchang rel june
flow key driver upsid believ abl
de-lever follow ge envista transact faster consensu
model forecast billion proce dental busi
spin base complet ipo debt financ payment envista
expect get net debt ebitda
believ allow resum meaning capit deploy
cut interest expens
wolf research pleas announc inaugur healthcar confer ny
novemb click regist view agenda
trade fundament data
upsid target
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
bridg ep estim
believ investor focus ep number reflect complet ge deal expect
full separ dental busi includ bridg impact year key move
piec reach ep estim inclus ge benefit exclud contribut
dental busi estim dental busi worth per share current
ahead street manag
guidanc ep larg part non-
oper item may reflect differ
assumpt debt associ ge deal
also reflect materi benefit lower
rate euro commerci paper
forecast ep growth
stand-alon basi prior impact
ge deal dental separ
consensu believ consensu ep
estim reflect combin stand-alon
ep forecast ep forecast inclus
estim ge deal add
ep detail exhibit estim
separ dental busi
remov ep estim
ge deal impact ahead manag prior
guidanc first year accret
note manag recent
out-performance ge busi
rel ep pro forma ge
deal dental separ forecast
organ ep growth
accret ge deal growth
ebit ge busi lower
interest expens debt paydown
exhibit wolf ep bridg estim ahead consensu
guidanc ep
note wolf ep estim exclud impact debt ge deal
page
put takeslowhighorgan estimate total organ revenu growthmargins- adj ebit margin expansionm a- drag revenu growth inc share ge deal share ge-associ debt raisedhr ep exclud ge-associ debt put takeslowhighorgan estimate total organ revenu adj ebit margin expansionm a- ex ge dental dealsfx- inc exp share full year ge share ge exclud dental spin impactm impactslowhighg compar guidanc base ebit put takeslowhighorgan estimate total organ revenu adj ebit margin expansiong revenu growth synergi margin expans inc debt paydown lower int exp share stock comp
valuat altern part method
exhibit valuat sensit ep
move piec busi
believ compar yield base target price
valuat sum part valuat
inform calcul per share valu
sharehold envista ipo
share distribut
shown bottom tabl exhibit base
current trade price detail
section envista busi
busi inclus ge deal
follow envista separ estim
ep detail exhibit appli
 multipl ep estim
approxim in-lin current price-to-earnings
multipl peer group
estim valuat share middl
tabl ex combin valu
envista share estim total valu
share top tabl ex
page
targetep cagrorganicdebt /fcf cagrcompani nametickerratingcurr pricefor ye market scienc tool ex small yieldp/etot remain co pro forma ge envista valu per share sharehold current share price impli ebitdaev/ebitda ep pro forma ge ex dental price-to-earnings ep pro forma ge ex dental price-to-earnings multipl
exhibit posit develop ge deal assumpt
estim ep pro forma ge deal
approach exclud dental separ
believ compar consensu
manag point two driver
estim deal out-performance ge
life scienc busi lower interest rate
debt issuanc exhibit also note
modestli outperform consensu also
current ep estim prior
dental separ partial reflect ge
busi out-performance interest rate
forecast prior forecast note reduct interest rate forecast
ge deal debt add ep interest rate forecast exhibit
exhibit forma estim ge deal
note wolf pro forma ep estim includ assum capit deploy express increment interest incom
page
-ge accret model base case total organ revenu growth annual revenu growth market sale revenu synergi cumul revenu synergi year pthnrevenu synergi per cycl busi slow emergeebitda ex cost annual organ margin expans synergi sale year sale anticip year non-gaap reconcili present deal tax non-gaap adjustmentspost-tax ebitda redirecteddebt paydown financ mcp impact financ cost prior net after-tax interest expect issu blend interest ratenet incom includ forma share reflect convers mcpsep impact per restructur chargesg ls net incom ep accret ep compound-annual-growth-rate post base ep stand-alon pre share account share issuanc alreadi modelnet guidanc ep accret guidanc first full year year forma share per net return growth impact organ includ ge-g accret assumptionsclos org tbdyear ep ep statusiniti compani forecast
transact consist
forma ge deal prior dental separ
potenti benefit lower cost debt estim
would issu billion debt financ ge
compani target billion transact
fund debt cash hand estim
split euro issu debt
futur us debt commerci paper
cash hand
initi guid ge deal accret
manag project debt issu
blend interest rate earn call
updat state debt financ
aid lower interest rate compani recent
issu billion euro denomin debt ge deal weight averag interest rate
estim blend tax interest rate pro forma merger model
manag comment low interest rate euro debt current low rate commerci paper
us debt indic lower overal interest expens believ interest rate could potenti even slightli
lower could drive higher level accret blend interest rate would accret
accret estim ahead guidanc out-performance busi lower interest rate
corpor debt combin support ep estim dental still includ
year accret rel estim prior impact ge deal associ dilut
share issu fund transact forecast accret deal progress quickli
manag origin guidanc first full year year
reflect out-performance ge busi lower interest rate accret estim year
reflect view ep accret come ahead manag origin guidanc
dhr dental divis close ipo septemb million share sold share price
repres share envista total valu equiti issuanc million
total equiti valu compani billion envista also issu billion debt cash payment back
indic total cash billion total enterpris valu envista billion
ipo price share current trade current enterpris valu envista billion
envista report million adjust ebitda give compani ev/ebitda
ebitda base current ev note envista report y/i declin adjust ebitda
respect trail month adjust ebitda million give compani
ev ttm ebitda
estim million adj ebitda million adj ebitda envista expect
ebitda stabil recov follow three year declin ebitda
depress lower overal price envista cost associ invest sale market
cover view valu equiti parti ipo
page
ep estimateinterest rateaccret lower interest rate
exhibit dental oper margin bridg comp
base current billion ev adjust ebitda estim million impli valuat
envista expect investor comp envista main public dental
manufactur ev ebitda though note grown adjust ebitda
outlook envista less certain
follow ipo retain ownership envista expect distribut
sharehold base valuat impli offer rang estim valu envista share
sharehold approxim per share
exhibit valuat sensit envista
exhibit valu per share sharehold
page
envista oper margin bridg annual ebitda oper adj ebitda gain dilut relat busi trade name impair product improv initi oper adj ebitda trade name impair product improv initi cost estimate liabil relat legal gain dilut relat busi oper adj ebitda oper margin bridg oper adj ebitda higher core sale volum lower spend product initi cost save product initiatives- lower overal pricing- increment cost associ sale market growth oper adj ebitda total combin impact- net impact new product develop growth invest fx product mix cost save lower core sale cost growth invest lower price fx net cost save ebitdaev/ebitda ebitdaev/ebitda multipl
ep impact dental spin
estim remov dental busi reduc ep base estim
dental segment adjust ebit expect report non-controlling intertest relat dental
busi own outsid sharehold compani complet spin busi approxim
ep drag non-controlling interest time full ep impact depend time
futur action take dental busi believ could guid ep impact
non-controlling interest includ busi still own would expect street
estim reflect convent
ep estim busi pro forma ge deal envista spin
ge pro forma ep less dental busi note earlier potenti
upsid lower financ cost ge out-performance
envista ipo rais million includ billion debt offer fund payment
would net billion envista note base estim billion pro forma ebitda
impact envista transact net debt ebitda would minim
billion debt paydown would off-set remov dental busi ebitda slightli lower avail
believ abil bring leverag faster investor anticip abl
return deploy capit larg acquisit share repurchas late pro forma ep
estim ge deal includ estim ep benefit capit deploy
capit deploy like develop number year acquisit share repurchas believ
contribut earlier investor expect accret like
exhibit forma leverag ratio ge deal
exhibit forma leverag ratio ge dental deal
note dental ebitda assumpt base ttm report adjust ebitda
page
net net forma ge ls net net forma ge ls acquisit dental spin
page
yieldfcf compound-annual-growth-rate ebitda compound-annual-growth-rate ev-ebitda vs estimate ebitda compound-annual-growth-rate tool ntm price-to-earnings ratio median price-to-earnings premium compound-annual-growth-rate
note figur million unless state per-shar term
page
note figur million unless state per-shar term
page
 sale detail mn adjust sell day revenu sci life wr organ bp bpsm estimate bp bp bp bp bp bp bp bp bpsother estimate bp bp bp bp bp bp bp bp bp wr organ bp bpsm bp bp bp bp bp bp bp bp bp bp bp bp bpsother bp bp bp bp bp bp bp bp bp bp bp bp wr organ bp bpsm bp bp bp bp bp bp bp bp bpsother bp bp bp bp bp bp bp bp bp bp bp bp bp bp wr organ bp bp bp bp bp bp bp bp bp bp bp bp bpsother bp bp bp bp bp bp bp bp bp bp bp bp bp
